US Stock Market Move | Research on drugs for essential tremor has made significant progress, leading to a 240% surge in Praxis Precision Medicines (PRAX.US).
On Thursday, Praxis Precision Medicines (PRAX.US) surged 240% in early trading, reaching a three-year high of $194.90.
On Thursday, Praxis Precision Medicines (PRAX.US) surged 240% in early trading, hitting a three-year high at $194.90. In terms of news, the company announced that the investigational drug Ulixacaltamide for essential tremor met its primary endpoints in two pivotal Phase III studies: Study 1 showed a 4.3-point improvement in Modified ADL-11 score at week 8 (p <0.0001), with all key secondary endpoints reaching statistical significance; Study 2 demonstrated significant maintenance effects (p = 0.0369) and the first key secondary endpoint reached statistical significance (p = 0.0042). The safety data for Ulixacaltamide was favorable, with no drug-related serious adverse events reported in either study, and tolerability consistent with previous trials. The company has submitted a pre-NDA meeting request with the FDA for Ulixacaltamide to advance the drug approval process.
Related Articles
International capital continues to increase! GIC further increases its holdings in Foundation Medicine (02616) by more than 8.2 million shares, with a stake of 6%.
Key points of the Securities Morning Meeting | The "anti-inward spiral" of the photovoltaic industry has become the core contradiction in the current industry. Optimistic about the direction of new technological iteration.
A-share pre-market report | Gold and silver surge to new highs together! Gold breaks through $4300 for the first time. Bankruptcy in the U.S. region sparks selling.
International capital continues to increase! GIC further increases its holdings in Foundation Medicine (02616) by more than 8.2 million shares, with a stake of 6%.
Key points of the Securities Morning Meeting | The "anti-inward spiral" of the photovoltaic industry has become the core contradiction in the current industry. Optimistic about the direction of new technological iteration.
A-share pre-market report | Gold and silver surge to new highs together! Gold breaks through $4300 for the first time. Bankruptcy in the U.S. region sparks selling.
RECOMMEND
